Heidelberg Pharma AG

Director's Dealing • Jun 28, 2012

News Details

Directors’ Dealings | 28 June 2012 21:06

DGAP-DD: WILEX AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. ————————————————————————— Details of the person subject to the disclosure requirement Company: dievini Hopp BioTech holding GmbH & Co. KG Person performing managerial responsibilities, triggering the disclosure requirement for the legal person Details of the person performing managerial responsibilities Position: Member of an administrative or supervisory body Information about the transaction with duty of notification Description of the financial instrument: Bearer shares of common stock ISIN/WKN of the financial instrument: DE0006614720 Type of transaction: Sale Date: 21.06.2012 Price: 3.51 Currency: EUR No. of items: 140390 Total amount traded: 492768.90 Place: Ausserbörslich / OTC Explanation for publication: The sale is attributed to the board members, who at the same time perform management duties for dievini Hopp BioTech holding GmbH & Co. KG. Information about the company with duty of publication Issuer: WILEX AG Grillparzerstr. 10 81675 München Deutschland ISIN: DE0006614720 WKN: 661472 End of Directors’ Dealings Notification (c) DGAP 28.06.2012 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 15585